Clinical trial
Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity…
NCT00467428 · NeuroSearch A/S, Industry · Completed
Key facts
| NCT number | NCT00467428 |
|---|---|
| Title | Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder |
| Official title | Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder. A Randomised, Double-Blind, Placebo-Controlled Study |
| Lead sponsor | NeuroSearch A/S, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | NS2359, Placebo |
| Enrollment | 126 |
| Start date | Aug 1, 2003 |
| Completion | Sep 1, 2004 |
| First posted | Apr 30, 2007 |
| Last update posted | Apr 30, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: